Literature DB >> 6780623

Purification to apparent homogeneity of murine interleukin 1.

S B Mizel, D Mizel.   

Abstract

Interleukin 1 was purified to apparent homogeneity from the culture fluid of P388D1 cell line macrophages by a procedure involving ammonium sulfate fractionation, phenyl Sepharose and Ultrogel AcA54 chromatographies, and preparative isoelectrofocusing. The interleukin 1 was purified more than 300-fold to a specific activity of approximately 1 X 10(6) U/mg protein. The purified interleukin 1 exhibited microheterogeneity. Three charge species, which we have termed alpha, beta, gamma, were resolved by Tris-glycinate discontinuous polyacrylamide gel electrophoresis. The partial amino acid content of the alpha species of interleukin 1 was determined. On the basis of the purification data, it appears that interleukin 1 is biologically active within the 10(-11) to 10(-10) M concentration range. The success of the purification was due in part to the use of a superinduction protocol that resulted in the production of interleukin 1 at a rate of approximately 1 microgram/24 hr/4 X 10(6) P388D1 cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6780623

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  64 in total

1.  Interleukin-1 induces chondrocyte protease production: the development of collagenase inhibitors.

Authors:  R D Pasternak; S J Hubbs; R G Caccese; R L Marks; J M Conaty; G DiPasquale
Journal:  Agents Actions       Date:  1987-08

2.  Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha.

Authors:  P Busson; K Braham; G Ganem; F Thomas; D Grausz; M Lipinski; H Wakasugi; T Tursz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

3.  Inducible release of an endothelial cell-specific protein.

Authors:  C W Carson; G G Hunder; K L Kaplan; C M Johnson
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

4.  Characteristics of human synovial fibroblast activation by IL-1 beta and TNF alpha.

Authors:  B D Gitter; J M Labus; S L Lees; M E Scheetz
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

5.  Effect of protein kinase C inhibitor (H-7) and calmodulin antagonist (W-7) on pertussis toxin-induced IL-1 production by human adherent monocytes. Comparison with lipopolysaccharide as a stimulator of IL-1 production.

Authors:  H Taniguchi; T Sakano; T Hamasaki; H Kashiwa; K Ueda
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

6.  A non-specific inhibitor produced by Candida albicans activated T cells impairs cell proliferation by inhibiting interleukin-1 production.

Authors:  G Lombardi; D Vismara; E Piccolella; V Colizzi; G L Asherson
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

7.  Primary in vitro plaque-forming cell response to DAGG-Ficoll: LPS-induced enhancement mediated by interleukin-1.

Authors:  J L Curtis; A A Nordin
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

8.  Role of Ia antigen expression and secretory function of accessory cells in the induction of cytotoxic T lymphocyte responses against herpes simplex virus.

Authors:  D S Schmid; H S Larsen; B T Rouse
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

9.  Demonstration of interleukin 1 activity in apparently homogeneous specimens of the pI 5 form of rabbit endogenous pyrogen.

Authors:  D F Hanson; P A Murphy
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

10.  Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes.

Authors:  E Kownatzki; A Kapp; S Uhrich
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.